TNYA   $2.38  10.19% Market Closed After Close 2.35 -1.26%

Tenaya Therapeutics Inc
Total Cash 99.30M
totalCashPerShare 1.259
EBITDA -118.31M
Total Debt 15.57M
quickRatio 5.942
currentRatio 6.285
Total Revenue
debtToEquity 11.622
Revenue/Share
ROA -0.41332
ROE -0.74544
grossProfits
freeCashflow -58.39M
operatingCashflow -97.84M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 92.19M
forwardPE -1.4294872
floatShares 54.21M
sharesOutstanding 78.89M
sharesShort 4.88M
sharesShortPriorMonth 5.22M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.74%
Short Ratio help_outline 9.77%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 1.699
Price To Book help_outline 1.31
earningsQuarterlyGrowth
netIncomeToCommon -120.74M
trailingEps -1.59%
forwardEps -1.56%
enterpriseToEbitda -0.78
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.37 3Q 2024
institutionsCount 137
lastUpdated Nov. 7, 2024, 5:13 a.m.